NEW YORK, June 12 – Affymetrix stock was down $14.10, or 34 percent, at $26.85 in afternoon trading on Tuesday, following an announcement on Monday after the close of trading that the company was slashing its second quarter revenue expectations.

The company said its revenues for the quarter would total between $44 million and $50 million, a drop of between $6 million and $14 million from previous estimates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.